• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌家族史会增加患前列腺癌的风险:EPICAP研究结果

Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study.

作者信息

Lamy Pierre-Jean, Trétarre Brigitte, Rebillard Xavier, Sanchez Marie, Cénée Sylvie, Ménégaux Florence

机构信息

Service Urologie, Clinique Beau Soleil, Montpellier, France.

Institut d'Analyse Génomique-Imagenome, Labosud, Montpellier, France.

出版信息

Oncotarget. 2018 May 4;9(34):23661-23669. doi: 10.18632/oncotarget.25320.

DOI:10.18632/oncotarget.25320
PMID:29805764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5955101/
Abstract

INTRODUCTION

Familial aggregation is now well established with an increased risk of prostate cancer in patients with a family history of prostate cancer in first degree relatives. The aim of this paper was to investigate the role of family history of cancer in first degree relatives in prostate cancer risk.

RESULTS

As expected, a family history of prostate cancer in first-degree relatives was more frequent in cases than in controls (OR 3.10, 95% CI 2.32-4.15). A family history of early BCa (before age 50) in first-degree relatives was more frequent in cases than in controls (OR 1.79, 95% CI 1.09-2.94) with higher risk of aggressive PCa. The association was more pronounced for BCa in daughters (OR 15.26 95% CI 1.95-120).

CONCLUSIONS

In summary, a family history of BCa in first degree relatives before age 50 may increases the risk of PCa with higher Gleason score. This finding could suggest a specific prostate surveillance and/or genetic counselling for men who present such familial history.

METHODS

EPIdemiological study of Prostate CAncer (EPICAP) is a population-based case-control study specifically designed to investigate the role of environmental and genetic factors in prostate cancer. Detailed information on family history of cancer in first degree relatives (parents, brothers and sisters, children) was collected as well as the age of occurrence and the localization of each cancer. Overall, 819 cases and 879 controls have been included.

摘要

引言

家族聚集现象现已得到充分证实,一级亲属中有前列腺癌家族史的患者患前列腺癌的风险会增加。本文旨在研究一级亲属的癌症家族史在前列腺癌风险中的作用。

结果

正如预期的那样,病例组中一级亲属有前列腺癌家族史的情况比对照组更为常见(比值比3.10,95%置信区间2.32 - 4.15)。一级亲属中有早期乳腺癌(50岁之前)家族史的情况在病例组中比对照组更为常见(比值比1.79,95%置信区间1.09 - 2.94),侵袭性前列腺癌的风险更高。女儿患乳腺癌的家族史与前列腺癌的关联更为显著(比值比15.26,95%置信区间1.95 - 120)。

结论

总之,50岁之前一级亲属中有乳腺癌家族史可能会增加 Gleason 评分较高的前列腺癌的风险。这一发现可能提示对有此类家族史的男性进行特定的前列腺监测和/或遗传咨询。

方法

前列腺癌流行病学研究(EPICAP)是一项基于人群的病例对照研究,专门设计用于调查环境和遗传因素在前列腺癌中的作用。收集了一级亲属(父母、兄弟姐妹、子女)癌症家族史的详细信息,以及每种癌症的发病年龄和发病部位。总体而言,共纳入了819例病例和879例对照。

相似文献

1
Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study.乳腺癌家族史会增加患前列腺癌的风险:EPICAP研究结果
Oncotarget. 2018 May 4;9(34):23661-23669. doi: 10.18632/oncotarget.25320.
2
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
3
Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.前列腺癌的流行病学研究(EPICAP):法国一项基于人群的病例对照研究。
BMC Cancer. 2014 Feb 19;14:106. doi: 10.1186/1471-2407-14-106.
4
First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis.一级乳腺癌家族史与前列腺癌风险相关:系统评价和荟萃分析。
BMC Cancer. 2019 Sep 2;19(1):871. doi: 10.1186/s12885-019-6055-9.
5
Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.癌症家族史与根据雌激素和孕激素受体状态定义的乳腺癌之间的关联。
Genet Epidemiol. 1996;13(2):207-21. doi: 10.1002/(SICI)1098-2272(1996)13:2<207::AID-GEPI6>3.0.CO;2-4.
6
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.家族性乳腺癌:对52项流行病学研究的个体数据进行的合作性重新分析,这些研究涵盖了58209名乳腺癌患者和101986名未患该病的女性。
Lancet. 2001 Oct 27;358(9291):1389-99. doi: 10.1016/S0140-6736(01)06524-2.
7
Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.乳腺癌和前列腺癌的家族聚集性与绝经后乳腺癌风险
J Natl Cancer Inst. 1994 Dec 21;86(24):1860-5. doi: 10.1093/jnci/86.24.1860.
8
Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculator.将瑞典家庭癌症数据库中的详细家族病史纳入前列腺癌预防试验风险计算器。
J Urol. 2015 Feb;193(2):460-5. doi: 10.1016/j.juro.2014.09.018. Epub 2014 Sep 19.
9
Impact of a Changing Population Structure and Clustering of Cancer in Prostate Cancer Patients Depending on a First-Degree Family History.基于一级亲属家族史的前列腺癌患者中人口结构变化和癌症聚集对其的影响。
Urol Int. 2020;104(3-4):222-229. doi: 10.1159/000504789. Epub 2019 Dec 20.
10
Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study.家族乳腺癌病史与亲属第二原发恶性肿瘤:一项全国性队列研究。
BMC Cancer. 2021 Nov 12;21(1):1210. doi: 10.1186/s12885-021-08925-y.

引用本文的文献

1
Prostate cancer risk reduction: promising prevention practices and insights.降低前列腺癌风险:有前景的预防措施与见解。
Ann Med Surg (Lond). 2025 May 30;87(7):4344-4355. doi: 10.1097/MS9.0000000000003451. eCollection 2025 Jul.
2
Variation in harms and benefits of prostate-specific antigen screening for prostate cancer by socio-clinical risk factors: A rapid review.前列腺癌前列腺特异性抗原筛查的危害与益处因社会临床风险因素而异:一项快速综述。
BJUI Compass. 2024 Feb 9;5(5):417-432. doi: 10.1002/bco2.326. eCollection 2024 May.
3
Pathogenic Variants as Biomarkers for Risk in Prostate Cancer.前列腺癌风险的生物标志物——致病变异体
Cancers (Basel). 2021 Nov 14;13(22):5697. doi: 10.3390/cancers13225697.
4
Addendum to "Familial prostate cancer and genetic predisposition".《“家族性前列腺癌与遗传易感性”补遗》
Urologe A. 2021 Sep 30. doi: 10.1007/s00120-021-01663-w.
5
Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro.表儿茶素和原花青素 B2 与多西他赛联合用于体外激素相关癌症的辅助治疗效果。
Int J Mol Sci. 2021 Jul 2;22(13):7178. doi: 10.3390/ijms22137178.
6
First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis.一级乳腺癌家族史与前列腺癌风险相关:系统评价和荟萃分析。
BMC Cancer. 2019 Sep 2;19(1):871. doi: 10.1186/s12885-019-6055-9.

本文引用的文献

1
Endocrine disruptors (EDs) and hormone-dependent cancers: Correlation or causal relationship?内分泌干扰物与激素依赖性癌症:相关性还是因果关系?
C R Biol. 2017 Sep-Oct;340(9-10):439-445. doi: 10.1016/j.crvi.2017.07.007.
2
Familial associations of male breast cancer with other cancers.男性乳腺癌与其他癌症的家族关联性。
Breast Cancer Res Treat. 2017 Dec;166(3):897-902. doi: 10.1007/s10549-017-4468-1. Epub 2017 Aug 23.
3
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer.双酚 A 及内分泌干扰物对人类前列腺癌影响的最新进展。
Mol Cell Endocrinol. 2017 Dec 5;457:35-42. doi: 10.1016/j.mce.2017.02.045. Epub 2017 Feb 28.
4
Common cancers share familial susceptibility: implications for cancer genetics and counselling.常见癌症具有家族易感性:对癌症遗传学和咨询的影响。
J Med Genet. 2017 Apr;54(4):248-253. doi: 10.1136/jmedgenet-2016-103932. Epub 2016 Sep 20.
5
Familial Associations Between Prostate Cancer and Other Cancers.家族性前列腺癌与其他癌症之间的关联。
Eur Urol. 2017 Feb;71(2):162-165. doi: 10.1016/j.eururo.2016.07.031. Epub 2016 Aug 4.
6
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.转移性前列腺癌男性患者的遗传性DNA修复基因突变
N Engl J Med. 2016 Aug 4;375(5):443-53. doi: 10.1056/NEJMoa1603144. Epub 2016 Jul 6.
7
[Prostate cancer incidence and mortality trends in France from 1980 to 2011].[1980年至2011年法国前列腺癌的发病率和死亡率趋势]
Prog Urol. 2015 Jul;25(9):536-42. doi: 10.1016/j.purol.2015.04.011. Epub 2015 Jun 1.
8
Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.女性健康倡议研究中乳腺癌和前列腺癌的家族聚集性以及绝经后乳腺癌的风险
Cancer. 2015 Apr 15;121(8):1265-72. doi: 10.1002/cncr.29075. Epub 2015 Mar 9.
9
Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.前列腺癌的流行病学研究(EPICAP):法国一项基于人群的病例对照研究。
BMC Cancer. 2014 Feb 19;14:106. doi: 10.1186/1471-2407-14-106.
10
The genetic epidemiology of prostate cancer and its clinical implications.前列腺癌的遗传流行病学及其临床意义。
Nat Rev Urol. 2014 Jan;11(1):18-31. doi: 10.1038/nrurol.2013.266. Epub 2013 Dec 3.